Breaking News

Alx Oncology Holdings (ALXO)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

0.64 -0.01 -1.53%

15/08 - Closed. Currency in USD

After Hours

0.64

0.00

0.00%

22:02:58 - Real-time Data

Type: Equity

Market: United States

Volume: 219,713
Bid/Ask: 0.00 / 0.00
Day's Range: 0.62 - 0.67

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Alx Oncology Holdings Company Profile

Get an in-depth profile of Alx Oncology Holdings , including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic in development as a combination therapy with other anti-cancer agents, including ASPEN-06, under Phase 2 clinical study for treating Gastric/GEJ cancer; ASPEN-07, under Phase 1 clinical study for treating urothelial cancer; and ASPEN-03 and ASPEN-04, both under Phase 2 clinical study for treating head and neck squamous cell carcinoma. It has collaboration agreement for Evorpacept combination programs comprising Jazz Pharmaceuticals plc for zanidatamab, under Phase 1 trial for the treatment of breast cancer and other solid tumors; Quantum Leap Healthcare collaborative with an ADC, fam-trastuzumab deruxtecan-nxki, under Phase 1 trial for the treatment of patients with breast cancer; MD Anderson Cancer Center with rituximab and lenalidomide for the treatment of patients with indolent and aggressive NHL; Sanofi with isatuximab and dexamethasone, under Phase 1/2 trial for the treatment of patients with relapsed or refractory multiple myeloma; Academic Gastrointestinal Cancer Symposium; and University of Pittsburgh with liposomal doxorubicin and pembrolizumab, under Phase 2 trial recurrent platinum-resistant ovarian cancer. In addition, the company has collaboration agreement with Tallac Therapeutics, Inc. for the development of ALTA-002, a potent immune activator targeted to myeloid cells in the tumor to promote innate and adaptive anti-cancer immune responses. It has license agreements with Board of Trustees of the Leland Stanford Junior University, Selexis SA, and Crystal Bioscience, Inc. The company was incorporated in 2015 and is headquartered in South San Francisco, California.

Contact Information

Address 323 Allerton Avenue
South San Francisco, 94080
United States

Phone 650 466 7125

Fax -

Web www.alxoncology.com

Top Executives

Name	Age	Since	Title
Graham Gordon Walmsley	34	2020	Independent Director
Jason W. Lettmann	47	2020	CEO & Director
Scott Garland	56	2022	Independent Director
Rekha Hemrajani	56	2020	Independent Director
Kipp Weiskopf	-	2020	Member of the Scientific Advisory Board
Charles M. Baum	67	2020	Member of the Scientific Advisory Board
Keith T. Flaherty	54	2020	Chair of the Scientific Advisory Board
Chris H. Takimoto	66	2025	Independent Director
Barbara J. Klencke	68	2025	Independent Director
Corey S. Goodman	73	2015	Independent Chairman
Daniel Curran	58	2025	Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

ALXO Comments

Write your thoughts about Alx Oncology Holdings

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,282.27	-20.65	-0.39%
NSE All Share	144,628.20	-738.83	-0.51%
US 30	44,842.0	-104.1	-0.23%
US 500	6,443.6	-6.2	-0.10%
FTSE 100	9,141.35	+2.45	+0.03%
DAX	24,270.70	-104.17	-0.43%
South Africa Top 40	94,435.54	-62.84	-0.07%

Brent Oil	65.75	-0.10	-0.15%
Crude Oil WTI	61.95	-0.03	-0.05%
Gold	3,392.67	+10.07	+0.30%
Silver	38.103	+0.127	+0.34%
Copper	4.4610	-0.0315	-0.70%
London Cocoa	5,604.00	+17.00	+0.30%
London Wheat	167.00	-2.40	-1.42%

Nigeria 10Y	15.677	+0.001	+0.01%
Nigeria 2Y	16.823	+0.001	+0.01%
U.K. 10Y	4.6660	-0.0300	-0.64%
Germany 10Y	2.7420	-0.0380	-1.37%
U.S. 10Y	4.294	-0.033	-0.76%
U.S. 5Y	3.819	-0.026	-0.68%
U.S. 2Y	3.744	-0.015	-0.40%

Fidelitybk	20.950	-0.050	-0.24%
Zenith Bank	72.40	+0.40	+0.56%
UBA	48.00	-0.30	-0.62%
First HoldCo	32.85	0.00	0.00%
Guaranty Trust Holding	97.70	+0.50	+0.51%
Sterling Bank	7.500	-0.400	-5.06%
Dangote Cement	577.00	0.00	0.00%

Recent Quotes

Name	Price	Chg.	Chg. %
ALXO	0.64	-0.01	-1.53%
084180	4,870	-130	-2.60%
ProShares Ultra F.	94.59	-2.16	-2.23%
Canara Robeco Fle.	339.190	+0.180	+0.05%
Lyxor UCITS SG Gl.	142.66	+0.50	+0.35%
JYC	4.860	-0.030	-0.61%
Invesco High Yiel.	2.957	-0.030	-1.13%
Bellevue Funds Lu.	388.200	-2.310	-0.59%

Market Movers

Name	Last	Chg. %	Vol.
Aiico	3.80	-9.31%	118.00M
Ellah Lakes	14.88	-6.42%	34.24M
First HoldCo	32.85	0.00%	23.96M
Guaranty Trust Holding	97.70	+0.51%	20.67M
UBA	48.00	-0.62%	13.99M
Zenith Bank	72.40	+0.56%	13.81M
Lafarge Africa	138.00	0.00%	5.07M

Name	Last	Chg. %	Vol.
Mutual Benefits Assurance	3.85	+10.00%	102.42M
Ikeja	22.650	+9.95%	4.00M
Wema Bank	22.75	+9.90%	2.11M
Deap Capital Management Trust	1.61	+9.52%	5.87M
Tripple Gee and Co	5.60	+8.32%	483.48K
Dangote Sugar	55.95	+6.57%	3.19M
Fidson	43.900	+5.91%	805.81K

Name	Last	Chg. %	Vol.
Lasaco Assurance PLC	4.05	-10.00%	52.85M
Linkassure	2.43	-10.00%	50.01M
International Energy Insurance	3.33	-10.00%	4.58M
Nem	32.500	-9.97%	607.38K
Meyer	16.75	-9.95%	300.54K
Regal Insurance	1.36	-9.93%	46.96M
Coronation Insurance	3.63	-9.93%	28.60M